Velneperit Inhibitor

Velneperit is potent and selective neuropeptide Y (NPY) Y5 receptor under evaluating for treatment,of obesity.

George M, Rajaram M, Shanmugam E. New and emerging drug molecules against obesity.[J]. J Cardiovasc Pharmacol Ther, 2014, 19(1):65-76.
George M, Rajaram M, Shanmugam E. New and emerging drug molecules against obesity.[J]. J Cardiovasc Pharmacol Ther, 2014, 19(1):65-76.
Shinichi Oda*, et al. Development of an Optimized Synthetic and Purification Process of S-2367 (Velneperit), a Novel Neuropeptide Y (NPY) Y5 Receptor Antagonist. Org. Process Res. Dev., 2015, 19 (4), pp 531-536.
Shinichi Oda*, et al. Development of an Optimized Synthetic and Purification Process of S-2367 (Velneperit), a Novel Neuropeptide Y (NPY) Y5 Receptor Antagonist. Org. Process Res. Dev., 2015, 19 (4), pp 531-536.

Small volumes of Velneperit, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5755692 is an inhibitor targeting Velneperit.